Dokter Kanker lambung stadium 2 di Luar Negeri — Halaman 3

Associate Professor Dr. Yusuf Acikgoz membawa keahlian dari Ohio State University dan keterlibatan aktif dalam uji klinis internasional untuk kanker lambung.

• Spesialisasi dalam Onkologi Medis dengan pelatihan di Rumah Sakit Pelatihan dan Penelitian Ankara Numune
• Asisten peneliti dalam studi Fase III CheckMate-649 dan Fortitude-101
• Anggota American Society of Clinical Oncology (ASCO) dan Perhimpunan Onkologi Medis Turki
• Tersertifikasi dalam Praktik Klinis yang Baik dan Perlindungan Subjek Manusia

Dr. Elkhan Mammadov is a medical oncologist. He focuses on cancer diagnosis and treatment, including cytotoxic chemotherapy, hormone therapy, targeted therapy (smart drugs), and immunotherapy.

Education: Azerbaijan Medical University, MD (2004–2010). Istanbul University, Istanbul Faculty of Medicine, Internal Medicine training (2014–2019). Istanbul Medipol Mega University Hospital, Medical Oncology subspecialty training (2019–2022).

Experience: 5 years in Internal Medicine. 3 years in Medical Oncology.

Memberships: Turkish Society for Medical Oncology. ESMO (European Society for Medical Oncology). ASCO (American Society of Clinical Oncology).

Profesor Köstler adalah seorang spesialis onkologi medis yang ahli dalam terapi kanker yang dipersonalisasi dan bertarget. Beliau berpraktik di Wiener Privatklinik yang ternama dan di Universitas Kedokteran Wina.

• Memiliki pengalaman lebih dari dua dekade di bidang penyakit dalam dan onkologi medis
• Ahli dalam kanker payudara, keganasan ginekologi, dan tumor padat
• Fokus pada terapi sistemik individual dan imunoterapi
• Wakil Kepala Onkologi Klinis di rumah sakit universitas terkemuka
• Aktif dalam jaringan onkologi Eropa dan penelitian klinis

Dr. Fox spesialis dalam pengobatan kanker lambung, menggabungkan kemoterapi, imunoterapi, dan terapi target untuk perawatan personal di Pusat Medis di Solingen.

• Hematolog, onkolog, dan imunolog bersertifikat dengan pengalaman 15+ tahun
• Ketua Dokter di pusat kanker interdisipliner bersertifikat
• Ahli dalam diagnostik molekuler dan pendekatan pengobatan inovatif
• Anggota aktif masyarakat penelitian kanker Jerman dan Amerika

Associate Professor Tahsin Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan saluran pencernaan di Rumah Sakit Universitas Istinye Liv.

• Lebih dari 10 tahun pengalaman onkologi di seluruh Turki
• Spesialisasi dalam kanker saluran pencernaan di Klinik Onkologi Ankara
• Dipromosikan menjadi Associate Professor pada tahun 2016
• Menempuh pendidikan di Fakultas Kedokteran Universitas Selcuk

Profesor Keil berspesialisasi dalam teknik pencitraan canggih untuk diagnosis kanker lambung yang presisi di Medical Center di Solingen.

• Lulus dengan pujian dari Julius-Maximilians-Universität Würzburg
• Menjadi ahli dalam MRI, CT, dan ultrasonografi untuk deteksi kanker
• Menjadi Kepala Dokter Radiologi Diagnostik dan Intervensional sejak 2022
• Menjalani pelatihan di bawah Profesor ternama Rolf W. Günther di Aachen

30+ tahun di bidang imunologi dengan fokus pada viroterapi – Dr. Jaunalksne menghadirkan pendekatan mutakhir dalam pengobatan kanker di Pallas Clinic.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Spesialisasi dalam salah satu bidang imunologi terbaru
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam

Spesialis dalam perawatan kanker lambung tingkat lanjut dengan keahlian dalam kemoterapi, imunoterapi, dan terapi target. Bekerja di Medical Park Antalya Hospital Complex.

• Tersertifikasi dalam onkologi medis
• Melakukan penelitian genetik generasi berikutnya dalam pengobatan kanker
• Menggunakan pendekatan pengobatan komplementer di samping perawatan konvensional
• Associate professor dari Universitas Akdeniz

Spesialis dalam bedah laparoskopi untuk kanker lambung – menempuh pendidikan di Universitas Istanbul, salah satu sekolah kedokteran terkemuka di Turki.

• Dokter bedah umum bersertifikat dengan pengalaman lebih dari 20 tahun
• Pelatihan lanjutan dalam bedah bariatrik laparoskopi dan onkologi kanker
• Keahlian dalam teknik invasif minimal untuk pemulihan pasien yang lebih baik

Dr. Alemdar spesialis dalam pengobatan kanker lambung dengan pengalaman lebih dari 15 tahun di bidang onkologi, menempuh pendidikan di Universitas Akdeniz.

• Tersertifikasi dalam Onkologi Medis sejak 2018
• Pengalaman luas di Rumah Sakit Universitas Akdeniz
• Bekerja di Kompleks Rumah Sakit Medical Park Antalya

Dr. Ercan Ozden berspesialisasi dalam pengobatan kanker lambung dengan pengalaman lebih dari 20 tahun di bidang penyakit dalam dan onkologi.

• Tersertifikasi dewan dalam onkologi medis dari Universitas Kocaeli
• Menempuh pendidikan di Universitas Istanbul – salah satu sekolah kedokteran terbaik di Turki
• Telah menangani kasus kanker lambung stadium 2 yang kompleks

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.